Data-independent acquisition (DIA): an emerging proteomics technology for analysis of drug-metabolizing enzymes and transporters

J Li, LS Smith, HJ Zhu - Drug Discovery Today: Technologies, 2021 - Elsevier
Data-independent acquisition (DIA) proteomics is a recently-developed global mass
spectrometry (MS)-based proteomics strategy. In a DIA method, precursor ions are isolated …

Quantitative proteomics in translational absorption, distribution, metabolism, and excretion and precision medicine

D Ahire, L Kruger, S Sharma, VS Mettu, A Basit… - Pharmacological …, 2022 - ASPET
A reliable translation of in vitro and preclinical data on drug absorption, distribution,
metabolism, and excretion (ADME) to humans is important for safe and effective drug …

Toward a consensus on applying quantitative liquid chromatography‐tandem mass spectrometry proteomics in translational pharmacology research: a white paper

B Prasad, B Achour, P Artursson… - Clinical …, 2019 - Wiley Online Library
Quantitative translation of information on drug absorption, disposition, receptor engagement,
and drug–drug interactions from bench to bedside requires models informed by …

Label-free absolute protein quantification with data-independent acquisition

B He, J Shi, X Wang, H Jiang, HJ Zhu - Journal of proteomics, 2019 - Elsevier
Despite data-independent acquisition (DIA) has been increasingly used for relative protein
quantification, DIA-based label-free absolute quantification method has not been fully …

Quantitative proteomics and mechanistic modeling of transporter‐mediated disposition in nonalcoholic fatty liver disease

A Vildhede, E Kimoto, RM Pelis… - Clinical …, 2020 - Wiley Online Library
Understanding transporter‐mediated drug disposition and pharmacokinetics (PK) in patients
with nonalcoholic fatty liver disease (NAFLD) is critical in developing treatment options …

Quantification of proteins involved in drug metabolism and disposition in the human liver using label-free global proteomics

N Couto, ZM Al-Majdoub, B Achour… - Molecular …, 2019 - ACS Publications
There is an urgent need (recognized in FDA guidance, 2018) to optimize the dose of
medicines given to patients for maximal drug efficacy and limited toxicity (precision dosing) …

From endogenous compounds as biomarkers to plasma‐derived nanovesicles as liquid biopsy; has the golden age of translational pharmacokinetics‐absorption …

D Rodrigues, A Rowland - Clinical Pharmacology & …, 2019 - Wiley Online Library
It is now established that a drug's pharmacokinetics (PK) absorption, distribution,
metabolism, excretion (ADME) and drug–drug interaction (DDI) profile can be modulated by …

Differential tissue abundance of membrane-bound drug metabolizing enzymes and transporter proteins by global proteomics

DK Singh, D Ahire, DR Davydov… - Drug Metabolism and …, 2024 - dmd.aspetjournals.org
Protein abundance data of drug-metabolizing enzymes and transporters (DMETs) are useful
for scaling in vitro and animal data to humans for accurate prediction and interpretation of …

Liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based proteomics of drug-metabolizing enzymes and transporters

J Li, HJ Zhu - Molecules, 2020 - mdpi.com
Liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based proteomics is a
powerful tool for identifying and quantifying proteins in biological samples, outperforming …

Multiple-enzyme-digestion strategy improves accuracy and sensitivity of label-and standard-free absolute quantification to a level that is achievable by analysis with …

JR Wiśniewski, C Wegler… - Journal of proteome …, 2018 - ACS Publications
Quantification of individual proteins is an essential task in understanding biological
processes. For example, determination of concentrations of proteins transporting and …